EUVIMEDEUVIMED entdecken
Open Access

Ingestible probes for breath-based monitoring of drug-metabolizing activity from the microbiome

Vishal A Manickam iD, Carly E Kimpling, Khoi N Le, Madeleine E Troussé iD, Amy Kang, Aarsh S Patel, Leslie W Chan iD

Science Advances · 14.08.2026 · 12 (33)

DOI: 10.1126/sciadv.aee2632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 14.08.2026. Verfasst von Vishal A Manickam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Glucuronidase, Microbiota. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to their effects on drug activity and safety, drug-metabolizing enzymes (DMEs) from the gut microbiome are attractive drug targets, and noninvasive strategies are needed to measure their activities. Here, we report the development of ingestible probes that sense and produce breath signals for β-glucuronidase (GUS), a microbiome DME that causes drug toxicity. GUS probes comprise safe-to-ingest components and release volatile reporters upon cleavage by GUS. After oral administration, probes transit the gastrointestinal tract intact until they reach the microbiome in the large intestine. There, probes are cleaved by GUS and release volatile reporters, which are rapidly exhaled to provide a near real-time breath signal for GUS activity that can be measured via mass spectrometry. In mouse studies, breath signals were produced in naïve mice with GUS-expressing microbiome but absent in microbiome-depleted mice. Repeated probe dosing and breath analysis enabled monitoring of dynamic changes in GUS activities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeGlucuronidaseMicrobiotaAnimalsBreath TestsMiceHumansAdministration, Oral

Substanzen

Glucuronidase

Autor:innen und Institutionen

  • Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA.
  • Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA 30332, USA.

ORCID-Profile: Vishal A Manickam, Madeleine E Troussé, Leslie W Chan

Förderung

  • NIBIB NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Cancer Institute
  • National Institute of General Medical Sciences
  • National Institute of Biomedical Imaging and Bioengineering
  • Georgia Tech President’s Undergraduate Research Award

Zitieren

APA

Manickam, V. A., Kimpling, C. E., Le, K. N., Troussé, M. E., Kang, A., Patel, A. S., & Chan, L. W. (2026). Ingestible probes for breath-based monitoring of drug-metabolizing activity from the microbiome. Science Advances, 12(33). https://doi.org/10.1126/sciadv.aee2632

Vancouver

Manickam VA, Kimpling CE, Le KN, Troussé ME, Kang A, Patel AS, et al. Ingestible probes for breath-based monitoring of drug-metabolizing activity from the microbiome. Science Advances. 2026;12(33). doi:10.1126/sciadv.aee2632

BibTeX
@article{Manickam2026,
  author = {Manickam, Vishal A and Kimpling, Carly E and Le, Khoi N and Troussé, Madeleine E and Kang, Amy and Patel, Aarsh S and Chan, Leslie W},
  title = {Ingestible probes for breath-based monitoring of drug-metabolizing activity from the microbiome},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {33},
  doi = {10.1126/sciadv.aee2632}
}
Kostenlos starten →